Autologous hematopoietic stem cell transplantation in multiple sclerosis
M. Sormani +6 more
semanticscholar +1 more source
CMV Reactivations During and After Letermovir Prophylaxis in Allogeneic Hematopoietic Stem Cell Transplantation: A Single-Center Experience. [PDF]
Olivari E +10 more
europepmc +1 more source
ABSTRACT Respiratory syncytial virus (RSV) is a common virus that causes respiratory infections, posing a serious threat, particularly to infants, the elderly, and individuals with compromised immune systems. As the leading cause of lower respiratory tract infections (LRTIs) in infants, RSV is responsible for millions of cases worldwide each year.
Jie Shi +6 more
wiley +1 more source
Multilineage hematopoietic reconstitution of supralethally irradiated rats by syngeneic whole organ transplantation: with particular reference to the liver [PDF]
Demetris, AJ +6 more
core
Recombinant human thrombopoietin in pediatric allogeneic hematopoietic stem cell transplantation: Clinical insights and future directions. [PDF]
Cui L, Deng JC, Zhang N.
europepmc +1 more source
ABSTRACT Pediatric patients with severe aplastic anemia (SAA) who undergo hematopoietic cell transplantation are at significantly increased risk of infertility. Pretransplant fertility preservation (FP) options for prepubertal children are surgical procedures: ovarian or testicular tissue cryopreservation (OTC and TTC). Bleeding and infection risk must
Christopher J. McCauley +3 more
wiley +1 more source
Immunosuppressive therapy and tolerance of organ allografts [PDF]
Starzl, TE
core +1 more source
Feasibility and acceptability of an online psychological group intervention for allogeneic hematopoietic stem cell transplantation inpatients. [PDF]
Haller K +4 more
europepmc +1 more source
Hemophilia A: An Ideal Disease for Prenatal Therapy
ABSTRACT Hemophilia A (HA) is the most common inherited coagulation defect. Current state‐of‐the‐art treatment consists of frequent administration of prophylactic infusions of coagulation factor VIII (FVIII) protein or bispecific antibodies that replace the cofactor function of FVIIIa to maintain hemostasis. However, these treatments are far from ideal,
Christopher D. Porada +2 more
wiley +1 more source

